Skip to content

Clinical trials

Phase 3 Hepatitis C, Chronic trials in Puerto Rico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 3 Country / region: Puerto Rico Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20061
20073
20082
20101
20112
20126
20173

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences5
AbbVie3
GlaxoSmithKline2
Hoffmann-La Roche2
Human Genome Sciences Inc.2
SciClone Pharmaceuticals2
Bausch Health Americas, Inc.1
Boehringer Ingelheim1
Debiopharm International SA1
Janssen Infectious Diseases BVBA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic22
Hepatitis C12
Hepatitis4
Digestive System Diseases1
Enterovirus Infections1
Fibrosis1
Flaviviridae Infections1
Hepatitis, Chronic1
Hepatitis, Viral, Human1
Liver Cirrhosis1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.